1. Pastan, I. et al. Characterization of monoclonal antibodies Bl and B3 that react with mucinous adenocarcinomas. Cancer Res. 51, 3781–3187 (1991).
2. Pai, L.H. & Pastan, I. Immunotoxin therapy for cancer. JAMA 269, 78 (1993).
3. Pai, L.H. & Pastan, I. Monoclonal antibodies in cancer therapy: Immunotoxins and recombinant toxins. in Biologic Therapy of Cancer 2nd edn. (eds DeVita, V.T., Hellman, S. & Rosenberg, S.A.) 521–533 (Lippincott, Philadelphia, 1995).
4. Vitetta, E.S. et al. Phase I immunotoxin trial in patients with B cell lymphoma. Cancer Res. 51, 4052–4058 (1991).
5. French, R.R., Hamblin, T.J., Bell, A.J., Tutt, A.L. & Glennie, M. Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin. Lancet 346, 223–224 (1995).